Advertisement
Home Tags Vaccines

Tag: Vaccines

Pfizer Will Ask FDA to Approve Its COVID Vaccine for Kids Under 5

Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11

Initial two-dose series of the Pfizer vaccine was authorized for that age group in October

FDA Postpones Decision on Pfizer COVID Vaccine for Kids Under 5

Antibiotic Use in Under 2s May Reduce Antibody Response to Vaccines

Possible negative association of history of antibiotic prescriptions with vaccine-induced immunity seen in young children

Teenage boy getting vaccination in his arm

Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose

In large cohort, there were 5.55 excess events per 100,000 vaccinees after BNT162b2 and 18.39 after mRNA-1273

Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination

Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines

doctor in medical gloves making injection to little girl in clinic

Vaccination Coverage in Kindergarteners Dropped in 2020 to 2021

3.9 percent of kindergarteners who did not have vaccine exemptions were not up to date for MMR in 2020 to 2021

Male doctor wearing gloves holding syringe taking coronavirus vaccine dose from vail preparing for covid 19 vaccination for patient. Flu influenza vaccine clinical corona virus treatment close up view

No Increased Risk for Appendicitis Reported With mRNA COVID-19 Vaccination

Findings from nationwide study in Denmark show no increased risk in association with vaccination or SARS-CoV-2 infection

AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients

CoVac-1, a peptide vaccine, induces T-cell immune responses in those with B-cell deficiencies, particularly leukemia and lymphoma patients

Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine

Difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization, severe COVID-19

Vaccination Mandate for Federal Workers Reinstated by Appeals Court

Moderna Says Its Combo Vaccine Effective Against Omicron

Company says the combination vaccine triggers antibodies capable of fighting several variants, including beta and omicron

COVID-19 Response Coordinator Says Adults Older Than 60 Should Get Second Booster

The FDA authorized a second booster of the Pfizer and Moderna vaccines on March 29 for anyone 50 years and older